R1 RCM Inc (RCM)
12.47
+0.02
(+0.16%)
USD |
NASDAQ |
May 03, 16:00
12.46
0.00 (0.00%)
After-Hours: 20:00
R1 RCM Enterprise Value: 6.711B for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 6.711B |
| May 02, 2024 | 6.702B |
| May 01, 2024 | 6.664B |
| April 30, 2024 | 6.635B |
| April 29, 2024 | 6.660B |
| April 26, 2024 | 6.471B |
| April 25, 2024 | 6.437B |
| April 24, 2024 | 6.446B |
| April 23, 2024 | 6.408B |
| April 22, 2024 | 6.475B |
| April 19, 2024 | 6.509B |
| April 18, 2024 | 6.521B |
| April 17, 2024 | 6.576B |
| April 16, 2024 | 6.601B |
| April 15, 2024 | 6.652B |
| April 12, 2024 | 6.711B |
| April 11, 2024 | 6.841B |
| April 10, 2024 | 6.807B |
| April 09, 2024 | 6.879B |
| April 08, 2024 | 6.837B |
| April 05, 2024 | 6.711B |
| April 04, 2024 | 6.774B |
| April 03, 2024 | 6.795B |
| April 02, 2024 | 6.769B |
| April 01, 2024 | 6.748B |
| Date | Value |
|---|---|
| March 28, 2024 | 6.883B |
| March 27, 2024 | 6.933B |
| March 26, 2024 | 6.933B |
| March 25, 2024 | 6.959B |
| March 22, 2024 | 6.933B |
| March 21, 2024 | 6.975B |
| March 20, 2024 | 6.996B |
| March 19, 2024 | 6.971B |
| March 18, 2024 | 7.005B |
| March 15, 2024 | 7.152B |
| March 14, 2024 | 7.215B |
| March 13, 2024 | 7.333B |
| March 12, 2024 | 7.370B |
| March 11, 2024 | 7.370B |
| March 08, 2024 | 7.303B |
| March 07, 2024 | 7.433B |
| March 06, 2024 | 7.324B |
| March 05, 2024 | 7.341B |
| March 04, 2024 | 7.349B |
| March 01, 2024 | 7.354B |
| February 29, 2024 | 7.375B |
| February 28, 2024 | 7.518B |
| February 27, 2024 | 7.597B |
| February 26, 2024 | 7.307B |
| February 23, 2024 | 6.135B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.136B
Minimum
Mar 18 2020
12.67B
Maximum
Aug 08 2022
5.585B
Average
6.459B
Median
Oct 17 2023
Enterprise Value Benchmarks
| Panamera Holdings Corp | 37.75M |
| Thermo Fisher Scientific Inc | 246.96B |
| Sotera Health Co | 5.088B |
| PetMed Express Inc | 36.22M |
| LENZ Therapeutics Inc | 354.49M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.40M |
| Revenue (Quarterly) | 575.10M |
| Total Expenses (Quarterly) | 497.30M |
| EPS Diluted (Quarterly) | 0.0055 |
| Gross Profit Margin (Quarterly) | 23.21% |
| Profit Margin (Quarterly) | 0.24% |
| Earnings Yield | 0.08% |
| Operating Earnings Yield | 4.77% |
| Normalized Earnings Yield | 1.449 |